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! Iridium tissue distribution and excretion in female Wistar rats following oral exposure
to iridium (III) chloride hydrate in drinking water (from 1 to 1000 ng/ml) in a sub-chron-
ic oral study were determined. Samples of urine, feces, blood and organs (kidneys, liver,
lung, spleen and brain) were collected at the end of exposure. The most prominent frac-
tions of iridium were retained in kidney and spleen; smaller amounts were found in lungs,
liver and brain. Iridium brain levels were lower than those observed in other tissues but
this finding can support the hypothesis of iridium capability to cross the blood brain bar-
rier. The iridium kidney levels rose significantly with the administered dose. At the high-
est dose, important amounts of the metal were found in serum, urine and feces. Iridium
was predominantly excreted via feces with a significant linear correlation with the ingest-
ed dose, which is likely due to low intestinal absorption of the metal. However, at the high-
er doses iridium was also eliminated through urine. These findings may be useful to help
in the understanding of the adverse health effects, particularly on the immune system, of
iridium dispersed in the environment as well as in identifying appropriate biological
indices of iridium exposure.
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INTRODUCTION
Catalytic converters were first fitted to light duty vehicles in the USA
and Japan in 1975, in response to new emission standards, such as the US
Clean Air Act Amendement (Beneman et al. 2005). Many other countries
with large vehicle markets have followed since then, including South
Korea (1987), Mexico (1989), the member states of the European Union
(1993), Brazil (1994) and China (2000) (Kendall 2004). These devices
simultaneously convert more than 90% of carbon monoxide (CO) and
nitrous oxides (NOx) and 80% of unburned hydrocarbons (HCs) from
exhaust emissions into less harmful carbon dioxide, nitrogen and water
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vapour (Onovwiona and Ugursal 2006; Twigg 2007). The catalytic con-
verter initially employed a combination of platinum (Pt), palladium (Pd)
and rhodium (Rh), with Pt and Pd being used to oxidize CO and HCs and
Rh facilitating the reduction of NOx. Today, there is a wide range of pos-
sible combinations and concentrations of Pt, Pd and Rh required by car
manufacturers that are used to achieve different catalyst performance
features. Moreover, recently, iridium (Ir) has been incorporated into cat-
alytic converter technology (the so called “De” catalyst) based on its
capacity to drastically reduce NOx emission in the exhausts of lean burn-
ing engines (Ravindra et al. 2004).
Therefore, it is reasonable to assume in the next years a possible
increase of Ir concentrations in the environment and consequently a
higher exposure both for the general population and subjects occupa-
tionally exposed to vehicle traffic (Botrè et al. 2007). In fact, the rapidly
changing redox conditions, high temperature, mechanical friction, abra-
sion and surface deterioration of the catalysts lead to Pt group elements
(PGEs) emission into the various compartments of the environment at
ng/km rates (Barefoot 1997; Artelt et al. 1999; Moldovan et al. 1999; Ek et
al. 2004).
As in the case of the other PGEs, the recent application of Ir in the
motor industry raised concerns about its increasing environmental levels
and the potential adverse health effects. However, the toxicological liter-
ature concerning Ir effects on human health is very limited. Indeed, it
was reported a case of contact dermatitis probably caused by exposure to
a Pt and Ir alloy (Sheard 1955) and a case of contact urticarioid response
with anaphylactic reactions in a worker of an electrochemical factory
exposed to Ir chloride (Bergman et al. 1995). There are also some studies
that, evaluating the effects of PGEs in workers of Pt refinery and catalyst
manufacturing and recycling factory, revealed positive prick test reactions
to Ir (Santucci et al. 2000; Cristaudo et al. 2005), while Marcusson et al.
(1998) found positive reactions to Ir trichloride in 1% of 205 subjects
with implanted dental alloys. These findings suggested the ability of this
metal to cause immune sensitization and toxic responses in humans. In
this regard, we have recently demonstrated that exposure of Wistar rats to
different doses of Ir (III) chloride hydrate was able to induce an immuno-
logical imbalance, with Th1 cytokines displaying a marked dose-depend-
ent decrease, whereas the Th2 cytokine IL-4 showed the opposite
response (Iavicoli et al. 2010).
Finally, some data concerning the toxicokinetics of Ir were provided
by experimental studies conducted several years ago, mostly on rats
(AECD 1951a, 1951b; Casarett et al. 1960). After inhalation of metallic-Ir
aqueous aerosols, metal was found in bronchi, larger bronchioles and in
parenchymal regions (Casarett et al. 1960). Ir was then eliminated by
lungs, with a half time of 6 h, while metal particles accumulated in the
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pulmonary parenchyma had a considerably slower clearance, with a half
time of 22–24 days. Findings showed that the major route of excretion was
via feces, for the 96% of the absorbed dose. The quantities of Ir redis-
tributed to organs and excreted in the urine in the study of Casarett were
much less than those observed by Hamilton (AECD 1951a, 1951b), prob-
ably because metal Ir is less soluble in water than Ir chloride and oxy-chlo-
ride. In more recent studies a size dependence of Ir particles distribution
was observed; a predominant retention of ultrafine insoluble particles in
the lung was shown 1 week after rat inhalation (Kreyling et al. 2002,
2009). The particles were then predominantly cleared via airways and lar-
ynx into the gastrointestinal tract and feces, but there was also a small
traslocation from lungs to blood circulation and to secondary target
organs (liver, spleen, heart, brain, and carcass). Also Semmler et al.
(2004) found that the most Ir amount in rats was retained in the lungs 3
weeks after a 2 or 6 months inhalation of insoluble ultrafine Ir particles,
while the clearance out of the body was solely via excretion. Moreover,
the study showed that extrapulmonary particle uptake decreased with
time in liver, spleen, heart and brain.
Recently a study of our group demonstrated that female Wistar rats
exposed to Ir in the drinking water (from 1 to 1000 ng/ml) for 90 days
displayed renal toxicity based on the elevated urinary retinol binding pro-
tein (RBP) and albumin (Iavicoli et al. 2011).
Apart from these few results, nothing is known about long-term Ir
absorption, its clearance pathways out of the body and systemic uptake
pathways toward secondary organs. In this context we carried out a 90-day
oral administration study with female Wistar rats exposed to different Ir
(III) chloride hydrate concentrations administered ad libitum in drinking
water, to investigate the distribution in internal organs and the elimina-
tion routes after oral administration. This type of treatment may simulate
the exposure humans receive in several environmental or occupational
conditions.
MATERIALS AND METHODS
Animals’ husbandry
The Experimental Animal Production Plant of the Università
Cattolica del Sacro Cuore (Rome, Italy) supplied twenty-eight female
Wistar rats used in this study. At the start of the experiment, all the ani-
mals were approximately three months old. The mean weight for the ani-
mals was 265 g with individual weights within ± 15% of the mean, and no
significant changes in body weight were observed at the end of the exper-
iments. Before being treated with Ir (III) chloride hydrate, the animals
were acclimated for two weeks and examined in order to confirm ade-
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quacy for the study. During the study the animals were individually
housed in Macrolon® cages (Tecniplast S.p.A., Buguggiate, Italy).
Room temperature and relative humidity were monitored and kept in
the range of 19.8-25.3 °C and 50-60%, respectively, while a 12-h day/night
cycle was maintained. Animals were fed with the solid maintenance diet
R (Altromin Rieper A. S.p.A., Vandoies, Italy). Diet was available to rats
without restrictions, as well as pure water or drinking water spiked with
iridium (III) chloride hydrate. Iridium was analyzed in the diet pellets but
the metal was undetectable in diet samples.
Sub-chronic exposure
The twenty-eight female Wistar rats selected for the study were ran-
domly divided into seven groups of four rats each. The preparation of Ir
solutions was performed by high-purity deionized water obtained by a
double demineralization system: a mixed bed Culligan cartridge
(Culligan Italiana S.p.A., Cadriano di Granarolo Emilia, Italy) and a
MilliQ A10 apparatus (Millipore, Bedford, MA, USA) connected in series.
The water had a resistivity of 18.2 MΩ_cm compensated for temperature
at 25 °C and total organic compounds of 2 ng/ml measured by photoxi-
dation. The solutions used for Ir administration had the following con-
centration of iridium (III) chloride hydrate (Alfa Aesar GmbH & CO KG,
Karlsruhe, Germany; as Ir) 0 (control group), 1, 10, 100, 250, 500, and
1000 ng/ml. The water solubility of the Ir salt used was sufficient to yield
clear and homogeneous stock solution of 1 mg/L. The actual concentra-
tion of the stock solution was check by analyzing three replicates; results
gave a maximum loss of the expected actual concentration <10%, fully
satisfactory for the aim of the study. Water was given ad libitum to the ani-
mals of each group for the entire period of Ir administration, resulting in
a daily ingestion of 19 ± 5 ml of Ir containing drinking water (averaged
on a total of 90 days) for each rat. The animals were sacrificed at the 90th
day, at the end of the exposure period, following the experimental pro-
tocol approved by the ethical committee of the Università Cattolica del
Sacro Cuore.
Urine and feces collection
Urine and feces were collected during a 24-h period in individual
metabolic cages at the 90th day. During the collection of the samples, no
food was supplied as the experimental protocol scheduled only drinking
water supplementation in the 24 h before sacrifice.
Blood collection and serum separation
On 90th day, rats were anesthetized with 0.5 mg of medetomine and
75 mg of ketamine per kg body weight. Blood was then collected from
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each of the twenty-eight animals in a 1.5 ml vial (Eppendorf srl, Milan,
Italy) by cardiac puncture. Serum was obtained after blood centrifugation
at 3,500 rpm per 15 min and stored at – 28 °C until analysis.
Organ collection
After the blood sampling, rats were euthanized by exsanguinations by
cutting both the abdominal aorta and vena cava. The organs sampled for
the study were kidneys, liver, lung, spleen and brain. These organs were
selected in order to achieve comparable results with the few literature
data available (AECD 1951a, 1951b; Casarett et al. 1960; Kreyling et al.
2002; Semmler et al. 2004; Kreyling et al. 2009).
Sample treatment
Samples of urine and serum were analyzed after 1:10 v/v dilution with
0.28 M HNO3 solution (ultrapur grade, Carlo Erba, Milan, Italy). Organs
(0.1-0.25 g) and feces (ca. 0.20 g) were dried and mineralized by a
microwave-assisted acidic digestion in Teflon vessels, and the digests were
diluted with high-purity deionized water to a volume of 20 ml prior to ana-
lytical measurements. The digestion procedure is deeply described else-
where (Iavicoli et al. 2001a). Food pellets (ca. 0.25 g) used to feed the rats
were freeze-dried (Lyolab 3000, Heto, Allerød, Denmark) for 72 h and,
then, mineralized by a microwave-assisted acidic digestion according to
the methods previously reported (Iavicoli et al. 2001a, 2001b). All concen-
tration values in feces and organs hereafter are reported on dry weight.
Iridium determinations
Iridium was determined by using a sector-field inductively coupled
plasma mass spectrometer (SF-ICP-MS) (Element-II, Thermo-Finnigan,
Bremen, Germany) equipped with Meinhard glass type nebulizer, water-
cooled spray chamber and nickel interface cones (Iavicoli et al. 2008).
The most abundant isotope, i.e. 193Ir, was selected for quantifications and
the low resolution setting (m/∆m = 300) was used because no significant
interference (i.e. 177Hf16O) affected the analytical mass. The addition cal-
ibration approach was adopted to quantify Ir in all the matrices, using
spiked solutions of pooled samples. All calibrants were daily prepared
from 1000 mg/L stock solutions of Ir (Spex Industries, Inc., Edison, NJ)
after subsequent dilutions with high-purity deionized water. Indium was
added at a concentration of 0.5 µg/l as internal standard in order to
account for possible instrumental drifts. Recoveries of the method, per-
formed by adding to control kidney (before digestion) a concentration of
Ir of 100 ng/l and 200 ng/l were 102% and 100%, respectively. In serum
and urine, the limit of detection (LoD) based on the 3σ criterion, was of
0.001 ng/l, while in tissues and feces was 0.002 ng/g.
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Statistical Analysis
The statistically significant differences between the doses of exposure
were analysed with the Kolmogorov-Smirnov test (p<0.05) that is more
appropriate than the Mann-Whitney U-test when the sample size is small,
as in this study. The correlation between doses of exposure and Ir con-
centrations in organs, feces, urine and serum was evaluated by a
Spearman test. The relative values of p and ρ were given in the notes in
each Table. It was also performed a statistical linear regression among tis-
sues and doses.
RESULTS
Data obtained on Ir concentrations in tissues, in serum, urine and
feces at the end of exposure period (90th day) are reported in Tables 1
and 2, respectively.
Statistically significant differences (p<0.01) between control group
and rats exposed to 1 ng/ml, were observed for all tissues and fluids
except for the feces. Likewise, statistically significant differences (p<0.01)
between doses of 1 ng/ml and 10 ng/ml and between doses of 100 ng/ml
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TABLE 1. Mean and standard deviation of Ir concentrations in tissues (ng/g, dry weight). 
Tissues
Dose (ng/ml) Liver* Spleen* Lung* Kidney* Brain*
0 0.015±0.02 0.007±0.002 0.015±0.02 0.03±0.02 0.005±0.001
1 0.13±0.05 0.41±0.07 0.17±0.04 0.95±0.17 0.02±0.01
10 0.86±0.13 4.06 ± 0.60 1.45±0.16 7.13±1.50 0.10±0.02
100 8.06±1.70 34.4 ± 8.30 12.8±2.30 66.2±27.6 2.80±4.30
250 33.3±2.60 114 ± 17.3 49.7±7.10 248±79.0 2.19±0.30
500 76.1±11.2 290 ± 53.0 118±20.0 507±182 4.31±1.40
1000 147±57.2 595 ± 222 258±101 1124±643 9.87±4.10
ρ: dose–response correlation, liver: 0.990; spleen:0.991; lung:0.990; kidney: 0.986; brain: 0.943; *
p<0.01 for all matrices.
TABLE 2. Mean and standard deviation of Ir concentrations in serum and urine (ng/ml), and
feces (ng/g, dry weight) in the different groups of exposure. 
Dose (ng/ml) Serum* (ng/ml) Urine* (ng/ml) Feces* (ng/g dry weight)
0 0.009±0.004 0.128±0.082 2.95±1.85
1 0.022±0.003 0.206±0.132 8.96±8.31
10 0.205±0.045 0.834±0.084 45.6±8.90
100 1.266±0.68 5.010±1.797 385±78.3
250 4.281±0.68 9.395±3.558 1412±380
500 13.00±6.30 26.26±7.325 1687±431
1000 32.10±10.2 51.64±12.97 4357±697
ρ: dose–response correlation serum: 0.988; urine: 0.981; feces: 0.973; * p<0.01 for all matrices.
and 250 ng/ml, were observed for all matrices except for brain. The dif-
ference between the doses 10 ng/ml and 100 ng/ml was statistically sig-
nificant for all tissues. Instead, no difference between the doses 250
ng/ml and 500 ng/ml was found for kidney, brain and feces.
Moreover, the linear regression showed a goodness of fit in terms of
a very high R2 for urine and feces (0.92 and 0.94, respectively), while for
the other organs it ranged from 0.75 (kidney) to 0.88 (spleen). The low-
est R2 (0.69) was observed for brain.
DISCUSSION AND CONCLUSIONS
The findings of this study demonstrated that the subchronic exposure
determined in female rats an increase of Ir in all organs but also in
serum, urine and feces.
Concerning the distribution, the greatest amount of Ir were found in
kidney and spleen, but high levels of the metal were also observed in lung
and liver. In particular, the high uptake in kidney could explain the renal
tubule dysfunction that we observed in a previous study (Iavicoli et al.
2011) and it should be investigated to verify if the kidney is the critical
organ. The elevated levels in spleen are very interesting and they could
be correlated to the immunological alterations that were previously
observed in the same model of animals subjected to the same experi-
mental conditions (Iavicoli et al. 2010). In particular, it was observed that
Ir exposure induced dose-dependent decrease (p<0.01) in T helper 1
(Th1) cytokines and increase (p<0.01) in a T helper 2 (Th2) cytokine.
Such findings suggested that Ir altered T helper formation and the spec-
trum of cytokines produced, with skewing toward a Th2 ‘’bias’’.
Therefore, Ir would be able to facilitate Th2 development among pre-
cursor Th(0) cells while inhibiting development of a Th1 pattern.
Literature data showed that at least one other metal, lead (Pb), exhibited
a very similar behaviour to that shown by Ir (Sun et al. 2009). In fact, in
mice, after intravenous injection of a lead nitrate solution, the highest Pb
levels was observed in kidney, followed by liver and spleen. Moreover, Pb
was also able to affect cytokines production in a similar manner to Ir.
Both in vivo and in vitro experiments showed increased plasma IL-4
and IgE levels and a profound decrease of INF-γ and IL-2 production,
indicating that Pb skews naïve T-cells toward Th2 (Heo et al. 1996, 1997;
Iavicoli et al. 2004, 2006; Kasten-Jolly et al. 2010). Moreover, Heo et al.
(1998) suggested that Pb inhibits Th1 development by increasing adeny-
late cyclase activity, and thereby increasing cyclic AMP levels. Considering
the similarities in cytokines production induced by Ir and Pb, it could be
interesting to verify if also Ir is able to use the same molecular mechanism
of action and to study if this metal plays a role in promoting antibody pro-
duction, including autoantibodies.
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It is noteworthy that a slight increase of brain Ir levels with the
increasing of the dose of exposure, was observed. This result could be
very interesting because it suggests the ability of Ir to cross the blood-
brain barrier and consequently it raises some concerns about a possible
role of this metal as neuro-toxic substance. In this regard literature data
are very limited. Göbbels et al. (2010), investigating the neurocompatibil-
ity of uncoated and coated (with Concanavalin A and poly-(D)-lysine)
pure Ir and different Ir oxides in thoracic neurons from adult locusts and
auditory brainstem neurons from embryonic chicken, found contrasting
results. In fact, the evaluation of engraftment of cells, survival during the
first three days in culture, and differentiation of neurons revealed that
different Ir oxides are neurocompatible to neuronal cells of locusts and
of limited neurocompatibility to chicken neurons from the auditory
brainstem. In particular, chicken cells grown on uncoated substrates
decreased in number to 50% and on coated substrates to 75% of starting
cell density. A similar study conducted by Thanawala et al. (2007) on rat
(Sprague-Dawley) cortical neurons, treated with amorphous and crys-
talline Ir oxide, showed that this metal is biocompatible and non-toxic for
neural cells but it was also observed a poor cell attachment of neurons
onto Ir oxides surfaces. Therefore, although Ir levels in soil (Müller and
Heumann 2000; Fritsche and Meisel 2004), road dust (Müller and
Heumann 2000; Djingova et al. 2003), plants or lichens (Djingova et al.
2003; Pino et al. 2010) and riverine or marine sediments (De Vos et al.,
2002; Lee et al., 2003) are very low, in the order of ng/g or in the order
of pg/m3 as in the case of airborne Ir levels (Rauch et al. 2006; Iavicoli et
al. 2008), special attention should be paid to the evaluation of possible
neurotoxic effects in working and general population and, particularly, in
children. Finally, the dose-dependent increase of Ir levels in serum
showed that the metal was distributed to the blood compartment.
Concerning the excretion, the findings revealed that the body clear-
ance of Ir took place mainly by elimination via feces and that this way of
elimination was dose-related. This significant correlation with the ingest-
ed dose is likely due to low intestinal absorption of Ir. Also urinary Ir lev-
els increased in a dose-dependent manner. Changes in urinary excretion
among different groups of exposure could be due to altered conditions
in the kidney of rats, as we previously observed in another study (Iavicoli
et al. 2011). Therefore, considering that collection of urine is an easy,
non-invasive and low-cost sampling method, these results suggested that
urine could be an appropriate matrix to assess the environmental and/or
occupational exposure to this metal. In this regard, our findings are par-
ticularly interesting although, to use the urinary levels of Ir as biomarkers
of exposure, it is desirable that future studies assess the kinetics of urinary
excretion of this metal.
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In conclusion, the subchronic study here reported provides helpful
data regarding the toxicokinetics of Ir and the target-organ toxicity of this
metal. However, further studies are needed to assess the potential renal
and neurological toxicity of Ir and to fully understand its effects on
immune system.
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